ClinConnect ClinConnect Logo
Search / Trial NCT01495689

Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting

Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Dec 19, 2011

Trial Information

Current as of June 09, 2025

Completed

Keywords

Smoking Cessation Respirology Out Patient Setting Smart Card

ClinConnect Summary

Design: Parallel group randomized control trial Method: All adult current smokers attending respirology clinic at the Ottawa General Hospital will be approached to participate. Concealed random allocation will be done if the subject is willing and signed the written informed consent. Experimental arm will receive counseling on site enrollment in the Ottawa Model of Smoking Cessation which includes IVR automated telephone follow-up and will receive a SmartCard worth $110 towards purchase of smoking cessation aids. Usual care arm will receive current usual care in our clinic i.e. strong physi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult \>18 years of age attending Respirology Clinic at the Ottawa General hospital
  • Current smokers (anyone who had smoked any form of tobacco in the 6 months prior to the clinic visit)
  • Willing to set quit dates in next 30 days
  • Exclusion Criteria:
  • Subjects with less than 2 year life expectancy (end stage cancer, end stage lung or heart disease etc) and/or receiving palliative care
  • Not willing to sign consent

About Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.

Locations

Ottawa, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Smita Pakhale, MD, FRCPC

Principal Investigator

OHRI

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials